Annual report [Section 13 and 15(d), not S-K Item 405]

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY

v3.25.0.1
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Stockholders' equity
Common stock
Treasury stock
Additional paid-in capital
Retained earnings
Accumulated other comprehensive loss
Noncontrolling interests
Series A Preferred stock
Total
Balance at Dec. 31, 2022 $ 69,714 $ 3 $ (7,169) $ 55,583 $ 24,166 $ (2,869) $ (1,124)   $ 68,590
Balance (in shares) at Dec. 31, 2022   31,735,423              
Stockholders' Equity                  
Stock-based compensation 5,032     5,032         $ 5,032
Stock-based compensation (in shares)   79,445              
Exercise of stock options (in shares)                 37,000
Exercise of stock options and warrants 310     310         $ 310
Exercise of stock options and warrants (in shares)   162,000              
Issuance of vested restricted shares, net of tax withholding (2,655)     (2,655)         (2,655)
Issuance of vested restricted shares, net of tax withholding (in shares)   488,988              
Purchase of treasury stock (7,882)   (7,882)           (7,882)
Purchase of treasury stock (in shares)   (1,181,881)              
Loss on foreign currency translation, net (61)         (61)     (61)
Net income (loss) 4,718       4,718   (692)   4,026
Balance at Dec. 31, 2023 69,176 $ 3 (15,051) 58,270 28,884 (2,930) (1,816)   $ 67,360
Balance (in shares) at Dec. 31, 2023   31,283,975              
Series A preferred stock, ending balance (Shares) at Dec. 31, 2023                 0
Stockholders' Equity                  
Stock-based compensation 6,018     6,018         $ 6,018
Stock-based compensation (in shares)   175,307              
Exercise of stock options (in shares)                 50,000
Exercise of stock options and warrants 242     242         $ 242
Exercise of stock options and warrants (in shares)   50,000              
Issuance of vested restricted shares, net of tax withholding (827)     (827)         (827)
Issuance of vested restricted shares, net of tax withholding (in shares)   271,762              
Purchase of treasury stock (3,151)   (3,151)           $ (3,151)
Purchase of treasury stock (in shares)   (743,201)             700,000
Warrants 10,771     10,771         $ 10,771
Loss on foreign currency translation, net (98)         (98)     (98)
Net income (loss) (15,824)       (15,824)   (829)   (16,653)
Series A Preferred Stock paid-in-kind dividend and accretion (19,142)     (6,082) $ (13,060)       (19,142)
Series A Preferred Stock paid-in-kind dividend and accretion               $ (19,100) (19,142)
Balance at Dec. 31, 2024 $ 47,165 $ 3 $ (18,202) $ 68,392   $ (3,028) $ (2,645)   44,520
Balance (in shares) at Dec. 31, 2024   31,037,843              
Temporary Equity                  
Series A Preferred Stock issuance               $ 138,943  
Series A Preferred Stock issuance ( in shares)               160,000  
Series A Preferred Stock paid-in-kind dividend and accretion               $ 19,142  
Series A preferred stock, ending balance (Amount) at Dec. 31, 2024               $ 158,085 $ 158,085
Series A preferred stock, ending balance (Shares) at Dec. 31, 2024                 160,000